CTKB
Income statement / Annual
Last year (2023), Cytek Biosciences, Inc.'s total revenue was $193.02 M,
an increase of 17.67% from the previous year.
In 2023, Cytek Biosciences, Inc.'s net income was -$12.15 M.
See Cytek Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$193.02 M
|
$164.04 M
|
$127.95 M
|
$92.84 M
|
$57.88 M
|
| Cost of Revenue |
$83.59 M |
$63.06 M |
$48.81 M |
$41.13 M |
$29.21 M |
| Gross Profit |
$109.43 M |
$100.97 M |
$79.14 M |
$51.71 M |
$28.67 M |
| Gross Profit Ratio |
0.57 |
0.62 |
0.62 |
0.56 |
0.5 |
| Research and Development
Expenses |
$44.15 M
|
$34.86 M
|
$24.44 M
|
$13.69 M
|
$8.93 M
|
| General & Administrative
Expenses |
$43.97 M
|
$34.69 M
|
$20.83 M
|
$9.37 M
|
$6.74 M
|
| Selling & Marketing
Expenses |
$49.15 M
|
$33.23 M
|
$24.71 M
|
$14.99 M
|
$10.24 M
|
| Selling, General &
Administrative Expenses |
$91.62 M
|
$67.92 M
|
$45.54 M
|
$24.36 M
|
$16.98 M
|
| Other Expenses |
$0.00 |
$1.02 M |
-$1.53 M |
$994,000.00 |
$252,000.00 |
| Operating Expenses |
$137.27 M |
$102.78 M |
$69.98 M |
$38.05 M |
$25.91 M |
| Cost And Expenses |
$220.86 M |
$165.84 M |
$118.78 M |
$79.18 M |
$55.12 M |
| Interest Income |
$6.41 M |
$4.62 M |
$49,000.00 |
$110,000.00 |
$711,000.00 |
| Interest Expense |
$2.07 M |
$2.57 M |
$1.74 M |
$333,000.00 |
$1,000.00 |
| Depreciation &
Amortization |
$9.23 M
|
$5.70 M
|
$1.24 M
|
$603,000.00
|
$309,000.00
|
| EBITDA |
-$4.41 M
|
$9.54 M
|
$10.40 M
|
$15.37 M
|
-$15.98 M
|
| EBITDA Ratio |
-0.02 |
0.02 |
0.06 |
0.17 |
0.07 |
| Operating Income Ratio
|
-0.14
|
-0.01
|
0.05
|
0.15
|
0.06
|
| Total Other
Income/Expenses Net |
$12.14 M
|
$3.06 M
|
-$3.22 M
|
$771,000.00
|
$962,000.00
|
| Income Before Tax |
-$15.71 M |
$1.26 M |
$5.95 M |
$14.43 M |
-$16.29 M |
| Income Before Tax Ratio
|
-0.08
|
0.01
|
0.05
|
0.16
|
-0.28
|
| Income Tax Expense |
-$3.56 M |
-$1.22 M |
$1.51 M |
-$4.98 M |
$533,000.00 |
| Net Income |
-$12.15 M |
$2.58 M |
$4.42 M |
$19.41 M |
-$16.83 M |
| Net Income Ratio |
-0.06 |
0.02 |
0.03 |
0.21 |
-0.29 |
| EPS |
-0.0898 |
0.0192 |
0.033 |
0.0242 |
-0.13 |
| EPS Diluted |
-0.0898 |
0.0186 |
0.033 |
0.0242 |
-0.13 |
| Weighted Average Shares
Out |
$135.28 M
|
$134.51 M
|
$133.75 M
|
$132.99 M
|
$132.99 M
|
| Weighted Average Shares
Out Diluted |
$135.28 M
|
$138.56 M
|
$133.75 M
|
$132.99 M
|
$132.99 M
|
| Link |
|
|
|
|
|
